Thumbnail

‘Promising’ results as first patients undergo PCI with next-generation pVAD device

The new product from California-based Supira Medical was designed to limit hemolysis and other complications among patients undergoing high-risk PCI or in cardiogenic shock

Thumbnail

Marijuana use linked to much higher risk of peripheral artery disease

New research presented at SCAI Scientific Sessions 2023 suggests that marijuana users should understand the early warning signs of PAD, including feelings of pain and coldness in the leg. 

Abbott TriClip device for TEER

EuroPCR 2023: Late-breaking research examines the latest in TEER, TAVR and PCI outcomes

Catch up on key late-breaking research from Abbott, Edwards Lifesciences and Philips presented at the four-day meeting in Paris. 

Thumbnail

Links to all the late-breaking trials for Heart Rhythm 2023

Heart Rhythm 2023, the society's 44th annual meeting, is scheduled for May 19-21. 

Marcelo DiCarli, MD, chief, division of nuclear medicine and molecular imaging, executive director for the cardiovascular imaging program, Brigham and Women's Hospital, discusses how artificial intelligence (AI) is impacting cardiac imaging.

What is the ROI for adopting AI in cardiac imaging?

Marcelo DiCarli, MD, and Rob Beanlands, MD, discussed the long-term value of investing in the development and implementation of AI technologies. 

To hear about key trends in cardiac imaging, Cardiovascular Business spoke with two experts in cardiac imaging at American College of Cardiology (ACC) 2023 meeting, Marcelo DiCarli, MD, chief, division of nuclear medicine and molecular imaging, executive director for the cardiovascular imaging program, Brigham and Women's Hospital, and Rob Beanlands, MD, is director of the National Cardiac PET Centre at the University of Ottawa Heart Institute, Canada.

What's new in cardiac imaging? 2 experts discuss the latest trends

Marcelo DiCarli, MD, and Rob Beanlands, MD, shared their thoughts on the current state of cardiac imaging at ACC.23. 

James Muller MD discusses vulnerable plaque and nuclear weapons as recipient of ACC Distinguished Scientist award. The right image in the near infrared spectroscopy system he developed to find vulnerable plaques.

Nobel Prize-winning cardiologist on his quest to find and treat vulnerable plaques

Pioneering cardiologist James Muller, MD, a winner of the Nobel Peace Prize, was one of the chief researchers that developed the concept of vulnerable plaques causing heart attacks. He was recently honored by the American College of Cardiology for his contributions.

Cardiologist Martha Gulati, MD, who specializes in both preventive cardiology and cardiovascular disease in women, has been named the Anita Dann Friedman Endowed Chair in Women’s Cardiovascular Medicine and Research at Cedars-Sinai in Los Angeles.

SCCT honors cardiologist Martha Gulati for her research on heart disease among women

Gulati, known for her work in the field of preventive cardiology, is also being recognized for her role in the development of the 2021 chest pain guidelines.